Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 380,766 | 306,980 | 264,734 | 194,392 | 82,705 |
| Cost of Goods | 18,942 | 12,135 | 12,670 | 4,577 | N/A |
| Gross Profit | 361,824 | 294,845 | 252,064 | 189,815 | 82,705 |
| Operating Expenses | 794,534 | 536,138 | 368,419 | 254,684 | 214,763 |
| Operating Income | -431,768 | -241,158 | -115,685 | -64,292 | -132,058 |
| Interest Expense | 56,352 | 12,491 | 12,554 | 12,094 | 8,276 |
| Other Income | 85,188 | 13,723 | 129 | -1,279 | -1,207 |
| Pre-tax Income | -402,932 | -239,926 | -128,110 | -77,665 | -141,541 |
| Income Tax | 35,228 | 11,650 | -29 | 1,335 | 569 |
| Net Income Continuous | -438,160 | -251,576 | -128,081 | -79,000 | -142,110 |
| Net Income | $-438,160 | $-251,576 | $-128,081 | $-79,000 | $-142,110 |
| EPS Basic Total Ops | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 |
| EPS Basic Continuous Ops | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 |
| EPS Diluted Total Ops | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 |
| EPS Diluted Continuous Ops | -6.64 | -4.27 | -2.75 | -2.02 | -4.17 |
| EPS Diluted Before Non-Recurring Items | -6.50 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-345,467 | $-210,206 | $-89,507 | $-45,642 | $-126,581 |